Published December 2, 2015 | Version v1
Journal article Restricted

CARTILOREGENEATM®-AU: An autologous chondrocyte-induced mesenchymal stem cell living cell transplant for the treatment of the cartilage defects on translating cartilopoeitic protein networks as evolutionary benchmarks of cartilo-protein interactions for the evaluation of stem dosimetric dosage clustering algorithms.

Authors/Creators

  • 1. Biogenea Pharmaceuticals Ltd

Description

CARTILOREGENEATM®-AU: An autologous chondrocyte-induced mesenchymal stem cell living cell transplant for the treatment of the cartilage defects on translating cartilopoeitic protein networks as evolutionary benchmarks of cartilo-protein interactions for the evaluation of stem dosimetric dosage clustering algorithms.

Files

Restricted

The record is publicly accessible, but files are restricted. <a href="https://zenodo.org/account/settings/login?next=https://zenodo.org/records/34553">Log in</a> to check if you have access.